PLRZ - Polyrizon Ltd Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of polyrizon-biotech.com (PLRZ)

Patent protection for FDA-certified polymer nanosprays creates a robust barrier for competitors. Polyrizon Ltd (PLRZ) attracts leading biochemists through a flexible corporate culture and RSU options. The development of mucosal protection systems ensures stable demand for consumables. The rolling annual sales volume indicator demonstrates revenue dynamics, while the value of 0.00 reflects the metric's balance.

PLRZ Polyrizon Ltd: Sales Growth YoY (Last Twelve Months) in the range 11/23/2025 - 11/15/2026

Polyrizon Limited (PLRZ) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Quote Chart Polyrizon Ltd.|PLRZ - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Polyrizon Ltd|PLRZ - Enterprise Value
- book capitalization information:
Book Value per Share Polyrizon|PLRZ - Company Book Value|Market Value to Book Value polyrizon-biotech.com|PLRZ - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Polyrizon Ltd|PLRZ - Long-Term Debt to Capital|Short-Term Debt to Capital Polyrizon Ltd|PLRZ - Company Debts|Debts to Book Capitalization Ratio Polyrizon Limited|PLRZ - Company Long-Term Debt|Short-Term Debt Polyrizon|Quick Liquidity polyrizon-biotech.com
- business earnings and investment ratios data:
PLRZ - Net Income|Expected Net Profit Polyrizon Ltd|PLRZ - Price to Earnings Ratio|Future Price to Earnings Multiple Polyrizon Ltd.|PLRZ - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Polyrizon Ltd.|PLRZ - Operating profit before deduction of amortization|Earnings per one share for the last 12 months Polyrizon|PLRZ - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months polyrizon-biotech.com|PLRZ - Earnings per share growth in current year|Projected earnings per share growth rate for next year Polyrizon Ltd
- sales and revenue data:
PLRZ - Company Sales|Company Future Revenue Polyrizon Ltd|PLRZ - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Polyrizon Ltd.|PLRZ - Revenue Growth YoY (Last 12 Months)
Analysis of all company metrics:Polyrizon, PLRZ
Mass-produced product of Polyrizon

For Polyrizon Ltd (PLRZ) and its unique barrier gels, this indicator reflects the effectiveness of commercializing patented technologies while bypassing price wars. By analyzing the company's TTM revenue growth rate, an investor can observe sliding revenue dynamics without reporting lags, enabling a prompt diagnosis of trend reversals and a real-time assessment of the business's scaling sustainability.

Competitors of Polyrizon Ltd (PLRZ)

VRTX (Vertex Pharmaceuticals Inc.) - Trailing Twelve Months Sales Growth|Alnylam Pharmaceuticals - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) INSM (Insmed Incorporated)|UTHR: Sales Growth YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BridgeBio Pharma Inc|Revenue Growth YoY (Last 12 Months) BGM Group Ltd (BGM)|Sales Growth YoY (Last Twelve Months) cogentbio.com (COGT)|Revenue Growth YoY (Last 12 Months) Xeris Biopharma XERS|Sales Growth YoY (TTM) KROS (kerostx.com)|Sales Growth YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Sales Growth YoY (TTM)|KMDA - Sales Growth YoY (TTM)|FULC (Fulcrum Corp) - Revenue Growth YoY (Last 12 Months)|ABEO (Abeona Therapeutics, Inc.) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (TTM) PLRX|Sales Growth YoY (Last Twelve Months) APLT (Applied Therapeutics)|Rein Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Gelteq Limited (GELS) - Trailing Twelve Months Revenue Growth|aytubio.com - Sales Growth YoY (TTM)|chemomab.com (CMMB) - Revenue Growth YoY (Last 12 Months)|SRXH: Sales Growth YoY (TTM)|Aeterna Zentaris (AEZS) - Sales Growth YoY (TTM)|CYTH (Cyclo Therapeutics) - Sales Growth YoY (TTM)|INZY: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Revenue Dynamics YoY (Last Twelve Months)